HSP90AB1 and lymphoma: In this study, we demonstrated that the binding of artesunate to Hsp90 reduces the expression of its client proteins AKT, ERK, p-AKT, p-ERK, and EGFR, thereby blocking the G0/G1 phase → S phase of lymphoma cells and inducing apoptosis.